The THRombolysis and STatins (THRaST) study

Objective: To assess the impact on stroke outcome of statin use in the acute phase after IV thrombolysis. Methods: Multicenter study on prospectively collected data of 2,072 stroke patients treated with IV thrombolysis. Outcome measures of efficacy were neurologic improvement (NIH Stroke Scale [NIHSS] ≤ 4 points from baseline or NIHSS = 0) and major neurologic improvement (NIHSS ≤ 8 points from baseline or NIHSS = 0) at 7 days and favorable (modified Rankin Scale [mRS] ≤ 2) and excellent functional outcome (mRS ≤ 1) at 3 months. Outcome measures of safety were 7-day neurologic deterioration (NIHSS ≥ 4 points from baseline or death), symptomatic intracerebral hemorrhage type 2 with NIHSS ≥ 4 points from baseline or death within 36 hours, and 3-month death. Results: Adjusted multivariate analysis showed that statin use in the acute phase was associated with neurologic improvement (odds ratio [OR] 1.68, 95% confidence interval [CI] 1.26–2.25; p < 0.001), major neurologic improvement (OR 1.43, 95% CI 1.11–1.85; p = 0.006), favorable functional outcome (OR 1.63, 95% CI 1.18–2.26; p = 0.003), and a reduced risk of neurologic deterioration (OR: 0.31, 95% CI 0.19–0.53; p < 0.001) and death (OR 0.48, 95% CI 0.28–0.82; p = 0.007). Conclusion: Statin use in the acute phase of stroke after IV thrombolysis may positively influence short- and long-term outcome.

[1]  Yi Li,et al.  Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke , 2003, Annals of neurology.

[2]  V. Hachinski,et al.  Predictors of major neurologic improvement after thrombolysis in acute stroke , 2005, Neurology.

[3]  M. A. Moro,et al.  Statin treatment withdrawal in ischemic stroke , 2007, Neurology.

[4]  Werner Hacke,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[5]  C. Molina,et al.  Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial , 2007, European journal of neurology.

[6]  Keith Muir,et al.  Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study , 2008, The Lancet.

[7]  A. Rabinstein,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2008 .

[8]  M. Hennerici,et al.  Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2009, Stroke.

[9]  M. Wintermark,et al.  Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  M. Chopp,et al.  Atorvastatin Extends the Therapeutic Window for tPA to 6 h after the Onset of Embolic Stroke in Rats , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  D. Tong.  Statins and stroke , 2009, Neurology.

[12]  G. Duckwiler,et al.  Impact of Hyperlipidemia and Statins on Ischemic Stroke Outcomes after Intra-Arterial Fibrinolysis and Percutaneous Mechanical Embolectomy , 2009, Cerebrovascular Diseases.

[13]  M. Boaz,et al.  Early Outcome of Acute Ischemic Stroke in Hyperlipidemic Patients Under Atorvastatin Versus Simvastatin , 2010, Clinical neuropharmacology.

[14]  S. Lakhan,et al.  Statins and clinical outcome of acute ischemic stroke: a systematic review , 2010, International archives of medicine.

[15]  P. Kelly,et al.  Response to Letter by Reeves Regarding Article, “Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke: The North Dublin Population Stroke Study” , 2011 .

[16]  G. Moretto,et al.  Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study , 2011, Journal of the Neurological Sciences.

[17]  L. Daly,et al.  Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke: The North Dublin Population Stroke Study , 2011, Stroke.

[18]  A. Zaninelli,et al.  Effect of prior medical treatments on ischemic stroke severity and outcome. , 2011, Functional neurology.

[19]  J. De Keyser,et al.  Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies. , 2011, Acta neurologica Belgica.

[20]  R. Delgado-Mederos,et al.  Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case–control study and a meta-analysis , 2011, Journal of Neurology.

[21]  R. Bordet,et al.  IV thrombolysis and statins , 2011, Neurology.

[22]  M. Endres,et al.  Statins and stroke: prevention and beyond. , 2011, Current opinion in neurology.

[23]  K. Furie,et al.  Statin Treatment and Functional Outcome After Ischemic Stroke: Case–Control and Meta-Analysis , 2011, Stroke.

[24]  L. Soinne,et al.  Association of Early National Institutes of Health Stroke Scale Improvement With Vessel Recanalization and Functional Outcome After Intravenous Thrombolysis in Ischemic Stroke , 2011, Stroke.

[25]  P. Michel,et al.  Blood pressure change and outcome in acute ischemic stroke: the impact of baseline values, previous hypertensive disease and previous antihypertensive treatment , 2011, Journal of hypertension.

[26]  A. Rocco,et al.  Impact of Statin Use and Lipid Profile on Symptomatic Intracerebral Haemorrhage, Outcome and Mortality after Intravenous Thrombolysis in Acute Stroke , 2012, Cerebrovascular Diseases.